First Treatment for Rare Autoimmune Neuromyelitis

The humanized monocolonal antibody eculizumab has been approved for adults with neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune inflammatory condition of the central nervous system (CNS). The disorder causes recurrent optic neuritis and myelitis, which may lead to permanent vision loss and paralysis.
Source: JAMA - Category: General Medicine Source Type: research